Strangvac 유럽 연합 - 크로아티아어 - EMA (European Medicines Agency)

strangvac

intervacc ab - recombinant streptococcus equi protein cce, recombinant streptococcus equi protein eq85, recombinant streptococcus equi protein idee - imunološke za kopitare - konji - for the active immunisation to reduce clinical signs and the number of abscesses in acute stage of infection with s. equi.

Ngenla 유럽 연합 - 크로아티아어 - EMA (European Medicines Agency)

ngenla

pfizer europe ma eeig - somatrogon - growth and development - hipofize i ГИПОТАЛАМИЧЕСКИЕ hormoni i analozi - indicated for the long-term treatment of paediatric patients with growth disturbance due to insufficient secretion of growth hormone.

VidPrevtyn Beta 유럽 연합 - 크로아티아어 - EMA (European Medicines Agency)

vidprevtyn beta

sanofi pasteur - sars-cov-2 prefusion spike delta tm protein, recombinant (b.1.351 strain) - covid-19 virus infection - cjepiva - vidprevtyn beta is indicated as a booster for active immunisation to prevent covid-19 in adults who have previously received an mrna or adenoviral vector covid-19 vaccine (see sections 4. 2 i 5. 1 in product information document). korištenje ovog cjepiva mora se provoditi u skladu sa službenim preporukama.

Cevenfacta 유럽 연합 - 크로아티아어 - EMA (European Medicines Agency)

cevenfacta

laboratoire francais du fractionnement et des biotechnologies - eptacog beta (activated) - hemophilia a; hemophilia b - antihemorrhagics - cevenfacta is indicated in adults and adolescents (12 years of age and older) for the treatment of bleeding episodes and for the prevention of bleeding in those undergoing surgery or invasive procedures in the following patient groups:in patients with congenital haemophilia with high-responding inhibitors to coagulation factors viii or ix (i. ≥5 bethesda units (bu)); in patients with congenital haemophilia with low titre inhibitors (bu.

Aranesp 유럽 연합 - 크로아티아어 - EMA (European Medicines Agency)

aranesp

amgen europe b.v. - darbepoetin alfa - anemia; cancer; kidney failure, chronic - ostali lijekovi противоанемические - liječenje simptomatske anemije povezane s kroničnim zatajenjem bubrega (crf) u odraslih i pedijatrijskih bolesnika. liječenje simptomatske anemije kod odraslih oboljelih od raka s миелоидными maligna новообразованиями primaju kemoterapiju.

RECORMON MD 50000 i.j./1 viala prašak i rastvarač za rastvor za injekciju 보스니아 헤르체고비나 - 크로아티아어 - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

recormon md 50000 i.j./1 viala prašak i rastvarač za rastvor za injekciju

roche d.o.o.roche ltd. - epoetin beta - prašak i rastvarač za rastvor za injekciju - 50000 i.j./1 viala - 1 bočica sa praškom za rastvor za injekciju sadrži: 50000 i.u. epoetin beta (humani rekombinantni eritropoetin)